Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma ... (ibing information available at Temoz...)

HOME >> MEDICINE >> TECHNOLOGY

Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme

Date:10/30/2007

ibing information available at http://www.temodar.com.

Important Information Regarding E.U. Labeling for TEMODAL

Temozolomide is marketed as TEMODAL(R) Capsules in the European Union and is indicated for the treatment of adult and pediatric patients with newly diagnosed glioblastoma multiforme (GBM) concomitantly with radiotherapy and subsequently as monotherapy treatment. It also is indicated for the treatment of malignant glioma, such as glioblastoma multiforme and anaplastic astrocytoma (AA), showing recurrence or progression after standard therapy.

About the EORTC

Created in 1962, the European Organisation for Research and Treatment of Cancer (EORTC) is a not-for-profit international cancer research organisation under the Belgian law. The EORTC has the mission to develop, conduct, coordinate and stimulate translational and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life. The ultimate goal of the EORTC is to improve the standard of cancer treatment in Europe, through the evaluation of new drugs and other innovative approaches, and to test more effective therapeutic strategies, using drugs which are already commercially available, or surgery or radiotherapy.

The EORTC has the aim to facilitate the passage of experimental discoveries into state-of-the-art treatment by keeping to a minimum the time lapse between the discovery of new anti-cancer agents and the implementation of their therapeutic benefit for patients with cancer.

The EORTC promotes multidisciplinary cancer research in Europe and is linked to other leading biomedical research organisations around the world. EORTC research takes place in over 300 hospitals, universities and cancer centers in 32 countries, and the unique network of investigators of the EORTC comprises more than 2000 clinicians collaborating on a voluntary bas
'/>"/>

SOURCE Schering-Plough Corp.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
3. 8-Year Long-term Data Demonstrate Prolonged Overall Survival and Length of Disease Remission with Bexxar
4. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
5. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
6. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
7. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
8. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
9. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
10. UCB Presents Long-Term CImzia Data in Crohns Disease
11. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week

Post Your Comments:

(Date:5/21/2013)... Wash. , May 21, 2013 IsoRay, Inc. ... today that it has entered into an exclusive international ... IsoRay,s complete product line in Greece ... in seed brachytherapy and medical radioisotope applications for brain ... and gynecologic ("gyn") cancer. IASIS Medical ...

(Date:5/21/2013)... Calif. , May 21, 2013 ... and manufacture of wireless personal healthcare products and ... its reach, announcing the release of two new ... blood pressure monitors and scales: the Wireless Pulse ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...

(Date:5/21/2013)... The North Shore-LIJ Health System is expanding a ... at North Shore University Hospital in Manhasset, ... at Forest Hills (NY) Hospital. ... new pilot program strengthens patient safety by providing hospitals ... first time in the US that remote video auditing ...

Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2 IsoRay Announces A New International Distributor For Greece 3 iHealth Lab adds new products and partners to mobile personal healthcare offering 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4

[0] IsoRay Announces A New International Distributor For Greece [0] iHealth Lab adds new products and partners to mobile personal healthcare offering [0] North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs

... Expand Testing Using Cellular ... Antioxidant Activity Assay, ... with the release of results from a new study,showing Wild ... red grapes and strawberries in an expanded,test using the Cellular ...

... Oct. 8 Vical Incorporated (Nasdaq: VICL ... nonclinical data,demonstrating that the company,s Vaxfectin(R) adjuvant may ... vaccines and,peptide-based cancer vaccines. Alain P. Rolland, Pharm.D., ... present the data today,Wednesday, October 8, at the ...

Cached Medicine Technology:Wild Blueberries Take Top Spot in New Antioxidant Research Study 2 Wild Blueberries Take Top Spot in New Antioxidant Research Study 3 Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2 Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3 Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4 Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5

Wild Blueberries Take Top Spot in New Antioxidant Research Study Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months

(Date:5/22/2013)... 2013 Athletic-Minded Traveler LLC, a ... released today its 2013 U.S. Business Hotel “Fit ... the company’s recommendation after ongoing research of over ... by the editorial staff. Selection criteria included ... court, etc.), in-room workout choices, healthy food offerings, ...

(Date:5/21/2013)... Swimsuit season is almost here. The "Get ... has begun with a 35% discount. , Cellulite forms mainly ... get the dreaded cellulite even if they are in shape. ... they have been stored as toxic lymph and smashed together, ... a specific program that works to dissolve the toxins and ...

(Date:5/21/2013)... 2013)Today the George Washington (GW) University School ... announced the launch of the Avance Center ... collaboration between SPHHS, the Maryland Multicultural Youth ... partners. This university-community partnership aims to address ... communities through research, mutual capacity building and ...

(Date:5/21/2013)... 2013 DISCcert has served the training ... use 17 DISC applications at the July 25 & ... , The July 25 & 26th DISC certification in ... of applying DISC. The time-tested, proven support materials will ... DISC training materials ; worksheets, handouts, learning ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 ContinuCare Home ... Texas Department of Aging and Disability Services. After completing ... employee interviews, ContinuCare Home Health was found to ... review is part of the Department of Aging and ... aging and disability services, supports and opportunities that ...

Breaking Medicine News(10 mins):Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2 Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2 Health News:GW launches center to address health disparities in the Latino immigrant community 2 Health News:GW launches center to address health disparities in the Latino immigrant community 3 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4 Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2

[0] 2013: The 10 Healthiest Business Hotels in the U.S.[0] Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale"[0] GW launches center to address health disparities in the Latino immigrant community [0] DISCcert Offers 17 Applications in Coming DISC Certification [0] ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services

... (Nasdaq: CYNO ), a leading developer and ... systems, today announced financial results for the three and ... Results Consistent with Cynosure,s January 15, 2009 announcement, ... were $25.5 million, reflecting the effect of deteriorating global ...

... Feb. 10 Novasys Medical, Inc., a developer of ... one of the nation,s leading health insurers with over ... treatment for stress urinary incontinence (SUI) in non-pregnant women ... undergo surgery for their condition. According to Aetna,s updated ...

... Kit Offers Extensive Enrollment Information and Insights into ... Feb. 10 HealthLeaders-InterStudy , a leading ... District Survival Kit designed to provide pharmaceutical sales ... and analysis that drives innovative sales strategy development.Each ...

... quarter decline in procedure volume rate shows signs of ... 48% Provides near-term financial outlook CINCINNATI, Feb. 10 ... LCAV ), a leading provider of laser vision correction ... financial and operating results for the three and 12 ...

... OSF HealthCare and Seattle Children,s Hospital among the ... software suiteCLEVELAND, Feb. 10 Healthcare organizations ... healthy lifestyle. Now, hospitals and health systems are ... preaching. Paper medical records cause costly errors, potentially ...

... AHPI ) reported that its net income for ... or zero cents per share in the,prior year period, to ... per,share, primarily because of lower sales volume in the current ... the second quarter fell about 8 percent, or almost $1.1,million, ...

Cynosure Reports Financial Results for the Fourth Quarter and Full Year 2008 Aetna Now Covers Novasys Medical's Renessa(R) Treatment for Incontinence in Women HealthLeaders-InterStudy Offers District Survival Kit to Arm Pharmaceutical Sales Teams With Local-Level Managed Care Market Intelligence LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results OnBase is the Choice for a Growing Number of Healthcare Organizations Allied Healthcare Reports Second Quarter Loss

... gas permeable contact lenses used for corneal ... nearsightedness (myopia). The patient wears the lenses ... wakening. During the day, nearsightedness is corrected ... Quadra RG contact lenses apply slight pressure ...

... all the major challenges to operating ... fair market fee for each procedure ... licensure requirements., Board Certified Nuclear Medicine ... camera., Hot Lab Equipment and Accessories., ...

... ,Type 330 ,Straight, ,Konan realized an ... illumination between lenses for observation. This ... in ophthalmology and otorhinolaryngology, ,Konan offers ... can; an advanced zoom function (1:3) ...

... and most experienced provider of mobile catheterization ... States. Mobile laboratories serving hospital networks are ... one hospital to another in a particular ... laboratory is fully equipped and operated by ...

Medicine Products:

Paragon Quadra RG (paflufocon B)Nuclear Cardiology Facility Planning Services Operation Microscope Mobile Catheterization Laboratories Serving Hospital Networks